Search

Your search keyword '"Abdulmajeed, Jazeel"' showing total 40 results
Start Over Author "Abdulmajeed, Jazeel"
40 results on '"Abdulmajeed, Jazeel"'

4. COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020–2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public health response

Author

Al-Kuwari, Mohamed Ghaith, Mohammed, Azza Mustafa, Abdulmajeed, Jazeel, Al-Romaihi, Hamad, Al-Mass, Maryam, Abushaikha, Shaikha Sami, Albyat, Soha, Nadeem, Shazia, and Kandy, Mujeeb Chettiyam

Published
2024
Full Text
View/download PDF

7. Impact and effectiveness of Pfizer BioNTech (BNT162b2) COVID-19 vaccine among adolescents (age 12yr to 15yrs), against SARS-COV-2 infection following a nationwide vaccination campaign: An observational study in Qatar.

Author

Azeez, Maktoum Abdul, primary, Hussain, Mir Saad, additional, Veettil, Shajitha Thekke, additional, Mesallam, Maha Saif Al, additional, Muhammed, Aysha Chalappurath, additional, Abdulmajeed, Jazeel, additional, and Krishnan, Jeyaram Illiayaraja, additional

Published
2024
Full Text
View/download PDF

13. Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10‐year forecasting model.

Author

Abushanab, Dina, Al‐Badriyeh, Daoud, Marquina, Clara, Liew, Danny, Al‐Zaidan, Manal, Ghaith Al‐Kuwari, Mohammed, Abdulmajeed, Jazeel, and Ademi, Zanfina

Subjects
TYPE 2 diabetes, CARDIOVASCULAR diseases, QUALITY-adjusted life years, MYOCARDIAL infarction, FORECASTING
Abstract

Aims: To predict the future health and economic burden of cardiovascular disease (CVD) in type 2 diabetes (T2D) in Qatar. Materials and Methods: A dynamic multistate model was designed to simulate the progression of fatal and non‐fatal CVD events among people with T2D in Qatar aged 40‐79 years. First CVD events [i.e. myocardial infarction (MI) and stroke] were calculated via the 2013 Pooled Cohort Equation, while recurrent CVD events were sourced from the REACH registry. Key model outcomes were fatal and non‐fatal MI and stroke, years of life lived, quality‐adjusted life years, total direct medical costs and total productivity loss costs. Utility and cost model inputs were drawn from published sources. The model adopted a Qatari societal perspective. Sensitivity analyses were performed to test the robustness of estimates. Results: Over 10 years among people with T2D, model estimates 108 195 [95% uncertainty interval (UI) 104 249‐112 172] non‐fatal MIs, 62 366 (95% UI 60 283‐65 520) non‐fatal strokes and 14 612 (95% UI 14 472‐14 744) CVD deaths. The T2D population accrued 4 786 605 (95% UI 4 743 454, 4 858 705) total years of life lived and 3 781 833 (95% UI 3 724 718‐3 830 669) total quality‐adjusted life years. Direct costs accounted for 57.85% of the total costs, with a projection of QAR41.60 billion (US$11.40 billion) [95% UI 7.53‐147.40 billion (US$2.06‐40.38 billion)], while the total indirect costs were expected to exceed QAR30.31 billion (US$8.30 billion) [95% UI 1.07‐162.60 billion (US$292.05 million‐44.55 billion)]. Conclusions: The findings suggest a significant economic and health burden of CVD among people with T2D in Qatar and highlight the need for more enhanced preventive strategies targeting this population group. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Effectiveness of Pfizer-BioNTech (BNT162b2) Vaccine Among Adolescents (Aged 12-15 Years): An Observational Study in Qatar.

Author

Azeez, Maktoum Abdul, Hussain, Mir Saad, Veettil, Shajitha Thekke, Al Mesallam, Maha Saif, Muhammed, Aysha Chalappurath, Abdulmajeed, Jazeel, and Krishnan, Jeyaram Illiayaraja

Subjects
DRUG efficacy, SCIENTIFIC observation, IMMUNIZATION, COVID-19 vaccines, RETROSPECTIVE studies, ACQUISITION of data, MEDICAL records, RESEARCH funding, PATIENT safety, EVALUATION
Abstract

In May 2021, Qatar launched the BNT162b2 COVID-19 vaccine campaign for adolescents aged 12 to 15 years across all 27 health centers. Our study assessed the safety and efficacy of the vaccine among vaccinated and nonvaccinated adolescents in Qatar. Using a retrospective observational study, we analyzed the medical records of 1956 adolescents who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive from June 17 to December 17, 2021. The mean age for the vaccinated group was 13.89 ± 0.93 years, and for the nonvaccinated group, it was 12.99 ± 0.93 years. In the vaccinated group, 46% were male (n = 185) compared with 53% in the nonvaccinated group (n = 827) and 54% were female in the vaccinated group (n = 217) versus 47% in the nonvaccinated group (n = 727). Our findings demonstrate satisfactory protection provided by the Pfizer-BioNTech COVID-19 vaccine, with only one fifth of the study population contracting SARS-CoV-2 infections after the double-dose regimen. These results highlight the importance of maximizing vaccination coverage and considering booster doses for adolescents to enhance protection. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Risk Factors for Acquiring Scrub Typhus among Children in Deoria and Gorakhpur Districts, Uttar Pradesh, India, 2017

Author

Thangaraj, Jeromie Wesley Vivian, Vasanthapuram, Ravi, Machado, Leonard, Arunkumar, Govindakarnavar, Sodha, Samir V., Zaman, Kamran, Bhatnagar, Tarun, Hameed, Shafeeq K. Shahul, Kumar, Arun, Abdulmajeed, Jazeel, Velayudhan, Anoop, Deoshatwar, Avinash, Desai, Anita S., Kumar, K. Hemanth, Gupta, Nivedita, Laserson, Kayla, and Murhekar, Manoj

Subjects
Uttar Pradesh, India -- Health aspects, Children -- Health aspects, Risk assessment -- Analysis, Scrub typhus -- Risk factors -- Research, Health
Abstract

Outbreaks of acute encephalitis syndrome (AES) with high case-fatality rates have been reported from Gorakhpur district, Uttar Pradesh, India, for >2 decades. These outbreaks occur during monsoon and postmonsoon seasons [...]

Published
2018
Full Text
View/download PDF

18. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar

Author

Bansal, Devendra, primary, Atia, Hassan, additional, Al Badr, Mashael, additional, Nour, Mohamed, additional, Abdulmajeed, Jazeel, additional, Hasan, Amal, additional, Al-Hajri, Noora, additional, Ahmed, Lina, additional, Ibrahim, Rumissa, additional, Zamel, Reham, additional, Mohamed, Almuthana, additional, Pattalaparambil, Hamad, additional, Daraan, Faisal, additional, Chaudhry, Adil, additional, Oraby, Sahar, additional, El-Saleh, Sahar, additional, El-Shafie, Sittana S., additional, Al-Farsi, Affra Faiz, additional, Paul, Jiji, additional, Ismail, Ahmed, additional, Al-Romaihi, Hamad Eid, additional, Al-Thani, Mohammed Hamad, additional, Doi, Suhail A. R., additional, Zughaier, Susu M., additional, Cyprian, Farhan, additional, Farag, Elmobashar, additional, and Farooqui, Habib Hasan, additional

Published
2023
Full Text
View/download PDF

19. Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study

Author

AbouGalala, Khalid, primary, Elsayed, Basant, additional, Elmarasi, Mohamed, additional, Kotob, Mona, additional, Taha, Reham, additional, Abbasher, Fardous, additional, Amarah, Ahmed, additional, El Hamawi, Mariam, additional, Albayat, Soha S., additional, Abdulmajeed, Jazeel, additional, Sallam, Mohamed A. H., additional, Al-Shamali, Maha H. M., additional, Al-Romaihi, Hamad E., additional, Bansal, Devendra, additional, Musa, Omran A. H., additional, Farag, Elmoubasher, additional, Al-Thani, Mohammed H. J., additional, Chivese, Tawanda, additional, and Emara, Mohamed M., additional

Published
2023
Full Text
View/download PDF

22. Dynamics of anti-S IgG antibodies titers after the second dose of COVID 19 mRNA and non-mRNA vaccines in the manual and craft worker population of Qatar

Author

Bansal, Devendra, primary, Atia, Hassan, additional, Badr, Mashael Al, additional, Nour, Mohamed, additional, Abdulmajeed, Jazeel, additional, Hasan, Amal, additional, Al-Hajri, Noora, additional, Ahmed, Lina, additional, Ibrahim, Rumissa, additional, Zamel, Reham, additional, Mohamed, Almuthana, additional, Pattalaparambil, Hamad, additional, Daraan, Faisal, additional, Chaudhry, Adil, additional, Oraby, Sahar, additional, El-Saleh, Sahar, additional, El-Shafie, Sittana S, additional, Al-Farsi, Affra Faiz, additional, Paul, Jiji, additional, Ismail, Ahmed, additional, Al-Romaihi, Hamad E., additional, Al-Thani, Mohammed H, additional, Doi, Suhail A.R., additional, Zughaier, Susu M, additional, Cyprian, Farhan, additional, Farag, Elmobashar, additional, and Farooqui, Habib Hasan, additional

Published
2022
Full Text
View/download PDF

24. Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease

Author

Bansal, Devendra, primary, Abdulmajeed, Jazeel, additional, Al-Shamali, Maha H. M. A., additional, Albayat, Soha S. A., additional, Himatt, Sayed M., additional, Cyprian, Farhan S., additional, Chivese, Tawanda, additional, Mundodan, Jesha M. A., additional, Khogali, Hayat S., additional, Baaboura, Rekayahouda, additional, Kaleeckal, Anvar H., additional, Kandy, Mujeeb C., additional, Latif, Ali Nizar, additional, Al-Kuwari, Mohamed Ghaith, additional, Al-Romaihi, Hamad Eid, additional, Al Khal, Abdullatif, additional, Bertollini, Roberto, additional, Al-Thani, Mohamed Hamad, additional, Farag, Elmobashar, additional, and Doi, Suhail A. R., additional

Published
2022
Full Text
View/download PDF

26. Impact of Smoking on COVID-19 Symptoms in Non-Vaccinated Patients: A Matched Observational Study from Qatar

Author

Haider, Mohammad Z, primary, Al-Mannai, Amna, additional, Al-Sirhan, Sally, additional, Elsabagh, Ahmed, additional, Nasser, Nasser, additional, Al-Quraishi, Noora, additional, Ouda, Amr, additional, Erradi, Khadija, additional, Ashour, Anas A, additional, Gupta, Ishita, additional, Abdulmajeed, Jazeel, additional, Al-Romaihi, Hamad E, additional, Bansal, Devendra, additional, Musa, Omran AH, additional, Abd Farag, Elmoubasher Abu Baker, additional, Al-Thani, Mohammed HJ, additional, and Al Moustafa, Ala-Eddin, additional

Published
2022
Full Text
View/download PDF

27. COVID-19 mRNA Vaccine Effectiveness Against Severe Disease

Author

Bansal, Devendra, primary, Abdulmajeed, Jazeel, additional, Yassin, Esraa, additional, Al-Shamali, Maha H. M. A., additional, Albayat, Soha S. A., additional, Himatt, Sayed M., additional, Cyprian, Farhan S., additional, Tawanda, Chivese, additional, Mundodan, Jesha M. A., additional, Mohamedbek, Hayat, additional, Baaboura, Rekayahouda, additional, Kaleeckal, Anvar H., additional, Kandy, Mujeeb C., additional, Latif, Ali Nizar, additional, Al-Kuwari, Mohamed Ghaith, additional, Al-Romaihi, Hamad Eid, additional, Al Khal, Abdullatif, additional, Bertollini, Roberto, additional, Al Thani, Mohammed Hamad, additional, Farag, Elmoubasher A., additional, and Doi, Suhail, additional

Published
2022
Full Text
View/download PDF

30. Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals

Author

Musa, Omran A. H., primary, Chivese, Tawanda, additional, Bansal, Devendra, additional, Abdulmajeed, Jazeel, additional, Ameen, Osman, additional, Islam, Nazmul, additional, Xu, Chang, additional, Sallam, Mohamed A., additional, Albayat, Soha S., additional, Khogali, Hayat S., additional, Ahmed, Shazia N. N., additional, Himatt, Sayed M., additional, Nour, Mohamed, additional, Elberdiny, Aiman A., additional, Abdallah, Abdallah Musa, additional, Furuya-Kanamori, Luis, additional, Al-Romaihi, Hamad E., additional, Doi, Suhail A. R., additional, Al-Thani, Mohammed H. J., additional, and Abu Baker Abd Farag, Elmoubashar, additional

Published
2021
Full Text
View/download PDF

35. The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings

Author

Sabeena, Sasidharanpillai, primary, Kuriakose, Santhosh, additional, Binesh, Damodaran, additional, Abdulmajeed, Jazeel, additional, Dsouza, Giselle, additional, Ramachandran, Amrutha, additional, Vijaykumar, Bindu, additional, Aswathyraj, Sushama, additional, Devadiga, Santhosha, additional, Ravishankar, Nagaraja, additional, and Arunkumar, Govindakarnavar, additional

Published
2019
Full Text
View/download PDF

36. Prevalence of multimorbidity among adults attending primary health care centres in Qatar: A retrospective cross-sectional study.

Author

Mohideen, Fathima, Rajkumar Honest, Prince, Syed, Mohamed, David, Kirubah, Abdulmajeed, Jazeel, and Ramireddy, Neelima

Subjects
PRIMARY care, ADULTS, COMORBIDITY, DISEASE clusters, AGE groups, ECZEMA, TYPE 2 diabetes
Abstract

Context: Multimorbidity (MM) is a global concern following the increase in life expectancy, the conquering of major infectious diseases, and the advances in the management of chronic illnesses. It places a substantial burden on patients and healthcare systems. Aims: This study aims to describe the prevalence and pattern of MM in adults among primary healthcare users in Qatar. Settings and Design: A retrospective cross-sectional study design. Methods and Material: Data were extracted from the electronic health records of patients aged 18 years and above who registered for care with 27 primary health centres in Qatar from 1st January 2017 to 30th June 2020. The distribution of MM among age groups, gender and nationality was analysed. Results: In the study population of 7,96,427, the prevalence of MM was found to be 22.1%. MM was more prevalent in females (51.2%) than males (48.8%). The prevalence of MM showed an increasing trend with increasing age, with a peak of 25.8% found in the 46–55 age group. Qatari nationals accounted for 32.7% of MM, Southeast Asians for 28.3%, North Africans for 16.7% and individuals from other Middle Eastern countries for 14.1%. The five most common long-term chronic conditions were type-2 diabetes mellitus, hypertension, dyslipidaemia, obesity and eczema, with the first three being the most prevalent disease clusters. Conclusions: Our findings confirm that MM is common in Qatar's primary care centres. While the prevalence of MM was found to increase with increasing age, the largest proportion of patients with MM were those aged 46–55 years. This information adds to the available data on MM and directs health policymakers towards tailoring the management for the same. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

37. Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection

Author

Arunkumar, Govindakarnavar, primary, Devadiga, Santhosha, additional, McElroy, Anita K, additional, Prabhu, Suresh, additional, Sheik, Shahin, additional, Abdulmajeed, Jazeel, additional, Robin, Sudandiradas, additional, Sushama, Aswathyraj, additional, Jayaram, Anup, additional, Nittur, Sudheesh, additional, Shakir, Mohammed, additional, Kumar, Keeriyatt Govindan Sajeeth, additional, Radhakrishnan, Chandni, additional, Sakeena, Karayil, additional, Vasudevan, Jayasree, additional, Reena, Kalathil Joseph, additional, Sarita, Ragini Lohithakshan, additional, Klena, John D, additional, Spiropoulou, Christina F, additional, Laserson, Kayla F, additional, and Nichol, Stuart T, additional

Published
2019
Full Text
View/download PDF

38. Persistence of Nipah Virus RNA in Semen of Survivor

Author

Arunkumar, Govindakarnavar, primary, Abdulmajeed, Jazeel, additional, Santhosha, Devadiga, additional, Aswathyraj, Sushama, additional, Robin, Sudandiradas, additional, Jayaram, Anup, additional, Radhakrishnan, Chandni, additional, Sajeeth, Kumar K G, additional, Sakeena, Karayil, additional, Jayasree, Vasudevan, additional, Reena, Joseph K, additional, and Sarita, Lohitakshan R, additional

Published
2018
Full Text
View/download PDF

39. Development and Evaluation of a Mobile App for Guiding Rabies Prophylaxis among Health-Care Professionals in India.

Author

Swathi, Muralidhar, Sabeena, Sasidharanpillai, Abdulmajeed, Jazeel, Pattanaik, Sarthak, Dsa, Oliver, Shubha, H. S., Varma, Muralidhar, Bhatt, Puneet, Ravishankar, Nagaraja, and Arunkumar, Govindakarnavar

Subjects
RABIES prevention, STATISTICAL correlation, INTERNET, WEB development, PREVENTIVE health services, QUESTIONNAIRES, RABIES, RELIABILITY (Personality trait), RESEARCH evaluation, SOFTWARE architecture, MOBILE apps, TERTIARY care
Abstract

Background: The majority of dog-mediated human rabies as well as rabies-related human deaths are reported from low-income countries of Asia and Africa where access to appropriate postexposure prophylaxis is limited or nonexistent. At present, India is second in position after China in terms of having the highest number of mobile phone users surpassing the United States. Objective: In this context, we decided to develop a user-friendly, technically less demanding, mobile App for health-care professionals, which is accessible even without Internet facility. Methodology: The current study was conducted in four phases, namely assemblage of informational contents on rabies, development of the software, assessment of the reliability of the questionnaire tool and evaluation of the mobile App. The evaluation of App was conducted among physicians and nursing staffs in a tertiary care referral hospital. Results: The information content was prepared referring national and international guidelines. The App was designed with Hypertext Markup Language 5 for presentation on the World Wide Web and was coined the name of "RabiApp." This is a hybrid App of the native App and web App, allowing the information to be stored in the local server. The mobile App was assessed using a validated and reliable questionnaire after confirming the internal consistency by means of Cronbach's alpha. The overall Cronbach's alpha for the main scale was 0.788, which was a respectable score. Conclusion: The developed App is a user-friendly, easily accessible platform, which can help health-care professionals in making decisions regarding rabies wound management, treatment, and prophylaxis. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

40. Persistence of Nipah Virus RNA in Semen of Survivor.

Author

Arunkumar, Govindakarnavar, Abdulmajeed, Jazeel, Santhosha, Devadiga, Aswathyraj, Sushama, Robin, Sudandiradas, Jayaram, Anup, Radhakrishnan, Chandni, Sajeeth, Kumar K G, Sakeena, Karayil, Jayasree, Vasudevan, Reena, Joseph K, and Sarita, Lohitakshan R

Subjects
*RIBAVIRIN, *RNA analysis, *AGE factors in disease, *BLOOD testing, *EPIDEMICS, *PARAMYXOVIRUSES, *POLYMERASE chain reaction, *URINALYSIS, *REVERSE transcriptase polymerase chain reaction, *SEMEN analysis, *RNA virus infections
Abstract

The article offers Nipah virus (NiV) which is emerging paramyxovirus with high mortality threatening to global security. Topics discussed reports of persistence of ebola virus and zika virus in semen of survivors and sexual route of transmission; virus research; nipah virus (NiV) which is emerging as paramyxovirus with high mortality threatening global security; and mentions the Kerala state government, India declared an outbreak of NiV in the Kozhikode district.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results